BioSpace News Archive

Celebrities, radio personalities and a nationwide community of urban, R&B and gospel music fans raised $1.5 million during the 13th annual Urban Radio Cares for St. Jude Kids fundraising broadcast on March 11-12 to support patients battling cancer and other life-threatening diseases at St. Jude Children’s Research Hospital®.

Gavi, the Vaccine Alliance, Louisville Metro, Ochsner Health, Penn State Health, Piedmont Healthcare and the State of California are using Salesforce technology to help manage their vaccine programs

– Dr. Kasibhatla brings deep drug development expertise across multiple mechanisms of action and therapeutic modalities, as well as a strong foundational understanding of tumor-intrinsic and immuno-oncology targets, to Boundless Bio –

Veteran Industry Executive joins Delix from Atlas Venture, after previously leading Shire Pharmaceuticals’ Global Neuroscience Business Delix has identified a class of non-hallucinogenic versions of psychedelic compounds, which the company is developing into safer, more effective, treatments for psychiatric and neurological disorders with high unmet needs

Exelixis, Inc. (Nasdaq:EXEL) today announced a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer for the ongoing phase 1b dose escalation study STELLAR-001 (previously called “XL092-001”), adding three new cohorts that will evaluate the safety and tolerability of XL092

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Indigo® System Lightning™ 7. Lightning 7 expands Penumbra’s offering of the Indigo Aspiration System with Intelligent Aspiration for mechanical thrombectomy and is designed for single session arterial thrombus removal.

UroGen today announced financial results for the fourth quarter and full year ended December 31, 2020 and provided an overview of the Company’s recent developments.

ENDRA Life Sciences Inc. , and Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) , a clinical-stage biopharmaceutical company focused on AI-driven therapeutic drug development for the treatment of NASH and liver disease, announced today the signing of a collaboration agreement

Novamind Inc., a leading mental health company specialized in psychedelic medicine, is pleased to announce that its wholly-owned subsidiary, Cedar Clinical Research has been selected as a key research site for a clinical trial focused on treatment-resistant depression by Merck & Co., a world-leading pharmaceutical company.

Halberd Corporation filed an International Patent Cooperation Treaty application for coverage of the invention titled, “Method for Treating and Curing Covid-19 Infection.” The Patent Cooperation Treaty has over 150 participating countries and allows an inventor to seek patent protection in numerous countries simultaneously.